305 related articles for article (PubMed ID: 19632201)
1. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
[TBL] [Abstract][Full Text] [Related]
2. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
[TBL] [Abstract][Full Text] [Related]
4. The miR-34 family in cancer and apoptosis.
Hermeking H
Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
[TBL] [Abstract][Full Text] [Related]
5. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
[TBL] [Abstract][Full Text] [Related]
6. Mutant p53 induces the GEF-H1 oncogene, a guanine nucleotide exchange factor-H1 for RhoA, resulting in accelerated cell proliferation in tumor cells.
Mizuarai S; Yamanaka K; Kotani H
Cancer Res; 2006 Jun; 66(12):6319-26. PubMed ID: 16778209
[TBL] [Abstract][Full Text] [Related]
7. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
[TBL] [Abstract][Full Text] [Related]
8. miR-15a and miR-16-1 downregulate CCND1 and induce apoptosis and cell cycle arrest in osteosarcoma.
Cai CK; Zhao GY; Tian LY; Liu L; Yan K; Ma YL; Ji ZW; Li XX; Han K; Gao J; Qiu XC; Fan QY; Yang TT; Ma BA
Oncol Rep; 2012 Nov; 28(5):1764-70. PubMed ID: 22922827
[TBL] [Abstract][Full Text] [Related]
9. p53 enters the microRNA world.
Hermeking H
Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
Luan S; Sun L; Huang F
Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
[TBL] [Abstract][Full Text] [Related]
11. p53-dependent activation of microRNA-34a in response to etoposide-induced DNA damage in osteosarcoma cell lines not impaired by dominant negative p53 expression.
Novello C; Pazzaglia L; Conti A; Quattrini I; Pollino S; Perego P; Picci P; Benassi MS
PLoS One; 2014; 9(12):e114757. PubMed ID: 25490093
[TBL] [Abstract][Full Text] [Related]
12. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
[TBL] [Abstract][Full Text] [Related]
13. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
[TBL] [Abstract][Full Text] [Related]
14. Apoptosis induced in human osteosarcoma cells is one of the mechanisms for the cytocidal effect of Ad5CMV-p53.
Wang J; Bucana CD; Roth JA; Zhang WW
Cancer Gene Ther; 1995 Mar; 2(1):9-17. PubMed ID: 7621257
[TBL] [Abstract][Full Text] [Related]
15. Berberine induces p53-dependent cell cycle arrest and apoptosis of human osteosarcoma cells by inflicting DNA damage.
Liu Z; Liu Q; Xu B; Wu J; Guo C; Zhu F; Yang Q; Gao G; Gong Y; Shao C
Mutat Res; 2009 Mar; 662(1-2):75-83. PubMed ID: 19159633
[TBL] [Abstract][Full Text] [Related]
16. Studies of the RB1 gene and the p53 gene in human osteosarcomas.
Scholz RB; Kabisch H; Weber B; Röser K; Delling G; Winkler K
Pediatr Hematol Oncol; 1992; 9(2):125-37. PubMed ID: 1524989
[TBL] [Abstract][Full Text] [Related]
17. miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response.
Scarola M; Schoeftner S; Schneider C; Benetti R
Cancer Res; 2010 Sep; 70(17):6925-33. PubMed ID: 20713524
[TBL] [Abstract][Full Text] [Related]
18. miR-125b suppresses the proliferation and migration of osteosarcoma cells through down-regulation of STAT3.
Liu LH; Li H; Li JP; Zhong H; Zhang HC; Chen J; Xiao T
Biochem Biophys Res Commun; 2011 Dec; 416(1-2):31-8. PubMed ID: 22093834
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic and genetic loss of Hic1 function accentuates the role of p53 in tumorigenesis.
Chen W; Cooper TK; Zahnow CA; Overholtzer M; Zhao Z; Ladanyi M; Karp JE; Gokgoz N; Wunder JS; Andrulis IL; Levine AJ; Mankowski JL; Baylin SB
Cancer Cell; 2004 Oct; 6(4):387-98. PubMed ID: 15488761
[TBL] [Abstract][Full Text] [Related]
20. p53-mediated activation of miRNA34 candidate tumor-suppressor genes.
Bommer GT; Gerin I; Feng Y; Kaczorowski AJ; Kuick R; Love RE; Zhai Y; Giordano TJ; Qin ZS; Moore BB; MacDougald OA; Cho KR; Fearon ER
Curr Biol; 2007 Aug; 17(15):1298-307. PubMed ID: 17656095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
